SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Syngene International informs about press release

26 Mar 2018 Evaluate

Syngene International has informed about press release titled ‘Syngene International signs R&D Agreement with GSK’.

The above information is a part of company’s filings submitted to BSE.

Syngene Internation. Share Price

437.05 0.95 (0.22%)
24-Jun-2026 13:01 View Price Chart
Peers
Company Name CMP
Syngene Internation. 437.05
Indegene 525.00
CMS Info Systems 301.00
JITF Infralogistics 320.35
Sagility 40.44
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: